Adamis Announces Inducement Option Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2022 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in...
Demand: Global Computer-aided Drug Discovery Market Estimated to Surpass $7,914.2 Million by 2028, and Grow at a CAGR of 15.0% during the Forecast Period [224-Pages] | Divulge By Research Dive
January 25, 2022 09:00 ET
|
Research Dive
New York, USA, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global computer-aided drug discovery market is estimated to garner a revenue of $7,914.2 million by 2028, and rise at...
Global Interventional Pulmonology Market Report 2021-2025 with Regional Analysis of Bronchoscopy Examination Procedures
January 20, 2022 05:03 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Interventional Pulmonology Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to...
EnBiotix, Inc. Closes $11M Pre-Merger Financing
December 29, 2021 02:30 ET
|
EnBiotix, Inc.
BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) -- EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible...
Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements
November 23, 2021 14:39 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 22, 2021 16:47 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update
November 19, 2021 15:34 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
October 04, 2021 07:30 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the appointment of Meera J. Desai, Ph.D., as a new director and member of the company’s...
Global Respiratory Disease Testing Market to Grow at a CAGR of 9.2% and Garner a Revenue of $20.1 Billion during the Forecast Period from 2020 to 2027 – Exclusive Report [227 Pages] By Research Dive
September 27, 2021 09:00 ET
|
Research Dive
New York, USA, Sept. 27, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global respiratory disease testing market explains the impact of COVID-19 pandemic on the...
Global Obstructive Lung Disease Management Markets 2021: Opportunities Led by Big Pharma and Medical Device Companies and New Collaborations in Developing Affordable and Quality-Driven Treatments
September 23, 2021 04:58 ET
|
Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Obstructive Lung Disease Management Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report provides a...